The goal of this clinical trial is to learn if an integrated digital and telemedicine care model works to manage decompensated cirrhosis in patients. It will also learn about the impact of this model on healthcare resource consumption and patient quality of life. The main questions it aims to answer are:

1. Does this telemedicine model lower the number of cirrhosis-related hospitalizations and emergency department visits?
2. Does the model reduce medical expenses and improve disease outcomes compared to standard care?

Researchers will compare the digital telemedicine care model (utilizing the NTUH-TPC platform and wearable devices) to standard health care to see if the digital approach effectively reduces hospital admissions and medical costs.

Participants will:

1. Use the NTUH telehealth platform (NTUH-TPC) to access records and upload physiological, medical, and imaging data.
2. Wear a smart watch for remote physiological monitoring. Receive continuous remote care and proactive follow-ups from case managers.

Inclusion Criteria:

1. Patients with decompensated cirrhosis and a Child score of B or C
2. Age: 18 years or older
3. Must return for a follow-up visit at least every 3 months

Exclusion Criteria:

1. Patients with active malignant tumors (those with a history of malignant tumors must have been cured for at least 2 years)
2. Patients with an expected survival of less than one year

To protect the patients' privacy information.